ArticleJournal of health economics and outcomes research2024

Matching-Adjusted Indirect Comparison of the Efficacy and Safety of Erdafitinib vs Enfortumab Vedotin in Patients with Locally Advanced Metastatic Urothelial Carcinoma.

Suzy Van Sanden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.